Patents Assigned to DERMASENSOR, INC.
  • Patent number: 11298025
    Abstract: A non-invasive, optical method and device for the detection of melanoma in skin lesions. The detection of the presence of melanoma is accomplished optically by looking for specific changes (signatures) in the spectrum of optical light elastically scattered off melanoma molecules. Elastic scattering spectroscopy (ESS) converts subcellular morphological changes into scattering spectrum signatures. A melanoma discrimination analysis is performed by illuminating the lesion with a handheld device that also collects a portion of the scattered light, converts it into digital signals, analyzes the requisite spectral signatures, and provides a logical output showing the user the presence (or absence) of melanoma in the subject lesion.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: April 12, 2022
    Assignee: DermaSensor, Inc.
    Inventors: John Noto, Robert Kerr, Maurice Ferre
  • Patent number: 9788730
    Abstract: A non-invasive, optical method and device for the detection of melanoma in skin lesions. The detection of the presence of melanoma is accomplished optically by looking for specific changes (signatures) in the spectrum of optical light elastically scattered off melanoma molecules. Elastic scattering spectroscopy (ESS) converts subcellular morphological changes into scattering spectrum signatures. A melanoma discrimination analysis is performed by illuminating the lesion with a handheld device that also collects a portion of the scattered light, converts it into digital signals, analyzes the requisite spectral signatures, and provides a logical output showing the user the presence (or absence) of melanoma in the subject lesion.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: October 17, 2017
    Assignee: DERMASENSOR, INC.
    Inventors: John Noto, Robert Kerr, Maurice Ferre
  • Publication number: 20130253335
    Abstract: A non-invasive, optical method and device for the detection of melanoma in skin lesions. The detection of the presence of melanoma is accomplished optically by looking for specific changes (signatures) in the spectrum of optical light elastically scattered off melanoma molecules. Elastic scattering spectroscopy (ESS) converts subcellular morphological changes into scattering spectrum signatures. A melanoma discrimination analysis is performed by illuminating the lesion with a handheld device that also collects a portion of the scattered light, converts it into digital signals, analyzes the requisite spectral signatures, and provides a logical output showing the user the presence (or absence) of melanoma in the subject lesion.
    Type: Application
    Filed: March 7, 2013
    Publication date: September 26, 2013
    Applicant: DERMASENSOR, INC.
    Inventors: John Noto, Robert Kerr, Maurice Ferre